TABLE OF CONTENTS
|  |  |  | Volume 35, Issue 6 (February 2016) |  | In this issue Reviews Original Articles Short Communication Corrigenda
Also new    AOP | |  |  |  | | Advertisement |  | Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. The journal has an Impact Factor of 3.952.
Explore the benefits of submitting your next research article. |  | | |  |  | Reviews | Top |  | Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategiesC Raggi, H S Mousa, M Correnti, A Sica and P Invernizzi Oncogene 2016 35: 671-682; advance online publication, May 11, 2015; 10.1038/onc.2015.132 Abstract | Full Text |  |  |  | Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesisJ Jeffery, D Sinha, S Srihari, M Kalimutho and K K Khanna Oncogene 2016 35: 683-690; advance online publication, April 27, 2015; 10.1038/onc.2015.128 Abstract | Full Text |  | Original Articles | Top |  | Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer OPENE G Seviour, V Sehgal, Y Lu, Z Luo, T Moss, F Zhang, S M Hill, W Liu, S N Maiti, L Cooper, R Azencot, G Lopez-Berestein, C Rodriguez-Aguayo, R Roopaimoole, C Pecot, A K Sood, S Mukherjee, J W Gray, G B Mills and P T Ram Oncogene 2016 35: 691-701; advance online publication, February 2, 2015; 10.1038/onc.2014.469 Abstract | Full Text |  |  |  | Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesisS H Lee, R Luong, D T Johnson, G R Cunha, L Rivina, M L Gonzalgo and Z Sun Oncogene 2016 35: 702-714; advance online publication, April 20, 2015; 10.1038/onc.2015.117 Abstract | Full Text |  |  |  | Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2H Fan, H Zhang, P E Pascuzzi and O Andrisani Oncogene 2016 35: 715-726; advance online publication, April 20, 2015; 10.1038/onc.2015.122 Abstract | Full Text |  |  |  | A tumor deconstruction platform identifies definitive end points in the evaluation of drug responsesR R Naik, A K Singh, A M Mali, M F Khirade and S A Bapat Oncogene 2016 35: 727-737; advance online publication, April 27, 2015; 10.1038/onc.2015.130 Abstract | Full Text |  |  |  | IGFBP2 potentiates nuclear EGFR–STAT3 signalingC Y Chua, Y Liu, K J Granberg, L Hu, H Haapasalo, M J Annala, D E Cogdell, M Verploegen, L M Moore, G N Fuller, M Nykter, W K Cavenee and W Zhang Oncogene 2016 35: 738-747; advance online publication, April 20, 2015; 10.1038/onc.2015.131 Abstract | Full Text |  |  |  | TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis OPENM-F Pang, A-M Georgoudaki, L Lambut, J Johansson, V Tabor, K Hagikura, Y Jin, M Jansson, J S Alexander, C M Nelson, L Jakobsson, C Betsholtz, M Sund, M C I Karlsson and J Fuxe Oncogene 2016 35: 748-760; advance online publication, May 11, 2015; 10.1038/onc.2015.133 Abstract | Full Text |  |  |  | PC4 promotes genome stability and DNA repair through binding of ssDNA at DNA damage sitesO Mortusewicz, B Evers and T Helleday Oncogene 2016 35: 761-770; advance online publication, May 11, 2015; 10.1038/onc.2015.135 Abstract | Full Text |  |  |  | Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus releaseK A Garant, M Shmulevitz, L Pan, R M Daigle, D-G Ahn, S A Gujar and P W K Lee Oncogene 2016 35: 771-782; advance online publication, May 11, 2015; 10.1038/onc.2015.136 Abstract | Full Text |  |  |  | Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivoW Huang, Z Dong, Y Chen, F Wang, C J Wang, H Peng, Y He, G Hangoc, K Pollok, G Sandusky, X-Y Fu, H E Broxmeyer, Z-Y Zhang, J-Y Liu and J-T Zhang Oncogene 2016 35: 783-792; advance online publication, June 15, 2015; 10.1038/onc.2015.215 Abstract | Full Text |  | Short Communication | Top |  | H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK OPENM M Olcina, K B Leszczynska, J M Senra, N F Isa, H Harada and E M Hammond Oncogene 2016 35: 793-799; advance online publication, May 11, 2015; 10.1038/onc.2015.134 Abstract | Full Text |  | Corrigenda | Top |  | CKIP-1 acts as a colonic tumor suppressor by repressing oncogenic Smurf1 synthesis and promoting Smurf1 autodegradationJ Nie, L Liu, G Xing, M Zhang, R Wei, M Guo, X Li, P Xie, L Li, F He, W Han and L Zhang Oncogene 2016 35: 800; 10.1038/onc.2015.28 Full Text |  |  |  | Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancerE G Seviour, V Sehgal, Y Lu, Z Luo, T Moss, F Zhang, S M Hill, W Liu, S N Maiti, L Cooper, R Azencot, G Lopez-Berestein, C Rodriguez-Aguayo, R Roopaimoole, C V Pecot, A K Sood, S Mukherjee, J W Gray, G B Mills and P T Ram Oncogene 2016 35: 801; 10.1038/onc.2015.177 Full Text |  |  |  | Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivoW Huang, Z Dong, Y Chen, F Wang, C J Wang, H Peng, Y He, G Hangoc, K Pollok, G Sandusky, X-Y Fu, H E Broxmeyer, Z-Y Zhang, J-Y Liu and J-T Zhang Oncogene 2016 35: 802; 10.1038/onc.2015.419 Full Text |  |  |  | BAX inhibitor-1 enhances cancer metastasis by altering glucose metabolism and activating the sodium-hydrogen exchanger: the alteration of mitochondrial functionG-H Lee, C Yan, S-J Shin, S-C Hong, T Ahn, A Moon, S J Park, Y C Lee, W H Yoo, H-T Kim, D-S Kim, S-W Chae, H-R Kim and H-J Chae Oncogene 2016 35: 803-804; 10.1038/onc.2015.421 Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment